Risk factor
Very high price volatility
Profitability factor
Very poor margins and returns
About
Seneca Growth Capital VCT plc operates as a venture capital trust, primarily focusing on providing growth-stage financing. The trust allocates capital to emerging biotechnology firms, with a strong inclination towards both unlisted and publicly traded companies within the MedTech industry. Its investment scope extends geographically across the United Kingdom, the French regions of Île-de-France and Burgundy, and other mature European markets. Financially, the fund typically targets businesses boasting annual revenues exceeding £10 million (around $11.90 million), a gross profit margin greater than 50%, and an operating profit margin above 10%.
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers.